Aurora Diagnostics Announces Acquisition of CBM Pathology of Maryland
PALM BEACH GARDENS, Fla. – Aurora Diagnostics, the nation’s largest independent integrated oncology diagnostics practice, today announced the acquisition of CBM Pathology, bringing to 31 the number of affiliated local pathology practices around the country.
Located in Gaithersburg, Md., CBM is a multi-specialty pathology practice that provides surgical services to ambulatory surgery centers and referring physician groups in Gaithersburg and the surrounding area. CBM was founded in 1999.
“We are delighted to welcome Dr. Carla MacLeod and the team at CBM Pathology to Aurora Diagnostics,” said Daniel D. Crowley, President, Chairman and CEO of AuroraDiagnostics. “CBM shares our commitment to providing accurate, timely, high-quality pathology services with an approach that emphasizes personal communication to efficiently connect all aspects of medicine for each patient.”
“Aurora Diagnostics is the national leader in high quality, community-based anatomic pathology, and we are extremely pleased to join with them,” Dr. MacLeod said. “We look forward to continuing to provide excellent service to our clients supported by the extensive resources, expertise and knowledge of the entire Aurora team.”
Four other practices were acquired by Aurora earlier in 2017 – University Pathologists in Warwick, RI; Pathology Associates of Princeton in Plainsboro Township, NJ; Cleveland Skin Pathology Laboratory, Inc. in Cleveland, OH; and CytoPath in Alabaster, AL.
Terms of the CBM transaction were not disclosed.
About Aurora Diagnostics
Aurora Diagnostics is the nation’s largest independent integrated oncology diagnostics company in the U.S. Its 31 community-based practices, with more than 190 boardcertified pathologists, offer integrated diagnostic and personalized medicine consultations to thousands of physicians.
Referring physicians include dermatologists, obstetricians and gynecologists, family practitioners, gastroenterologists, urologists, general surgeons, and oncologists. Aurora pathologists provide diagnostic opinions and work collaboratively with them to determine appropriate patient treatment options.
Aurora Diagnostics is also a leader in hospital lab management services, supporting nearly 200 hospitals and surgery centers throughout the country.
Additionally, the Company’s Aurora Research Institute subsidiary is a leader in helping hospitals and independent labs ethically provide tissue and blood samples to researchers on the cutting edge of research for effective cancer treatments.
For additional information regarding Aurora Diagnostics and the services it provides, please visit the company website at www.auroradx.com.